Literature DB >> 2810603

Differential diagnosis of acute meningitis. An analysis of the predictive value of initial observations.

A Spanos1, F E Harrell, D T Durack.   

Abstract

We analyzed data from the records of 422 patients with acute bacterial or viral meningitis. A cerebrospinal fluid (CSF) glucose level less than 1.9 mmol/L, a CSF-blood glucose ratio less than 0.23, a CSF protein level greater than 2.2 g/L, more than 2000 x 10(6)/L CSF leukocytes, or more than 1180 x 10(6)/L CSF polymorphonuclear leukocytes were individual predictors of bacterial infection with 99% certainty or better. Although any one of these tests could rule in bacterial meningitis with high probability, none could rule it out. To better predict whether a patient has bacterial vs viral infection, we developed a logistic multiple regression model using CSF-blood glucose ratio, total polymorphonuclear leukocyte count in CSF, age, and month of onset. This proved highly reliable when validated in an independent test sample, with an area under receiver operating characteristic curve of 0.97. The model should allow physicians to differentiate between acute viral and acute bacterial meningitis with greater accuracy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2810603

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  67 in total

Review 1.  Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis.

Authors:  Matthijs C Brouwer; Allan R Tunkel; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

2.  CSF lactate for accurate diagnosis of community-acquired bacterial meningitis.

Authors:  S Giulieri; C Chapuis-Taillard; K Jaton; A Cometta; C Chuard; O Hugli; R Du Pasquier; J Bille; P Meylan; O Manuel; O Marchetti
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-08-19       Impact factor: 3.267

3.  Accuracy of clinical presentation for differentiating bacterial from viral meningitis in adults: a multivariate approach.

Authors:  François G Brivet; Sophie Ducuing; Frédéric Jacobs; Isabelle Chary; Roger Pompier; Dominique Prat; Bogdan D Grigoriu; Patrice Nordmann
Journal:  Intensive Care Med       Date:  2005-10-22       Impact factor: 17.440

4.  How to differentiate bacterial from viral meningitis.

Authors:  Werner Zimmerli
Journal:  Intensive Care Med       Date:  2005-10-22       Impact factor: 17.440

5.  Linking surveillance to action: incorporation of real-time regional data into a medical decision rule.

Authors:  Andrew M Fine; Lise E Nigrovic; Ben Y Reis; E Francis Cook; Kenneth D Mandl
Journal:  J Am Med Inform Assoc       Date:  2007-01-09       Impact factor: 4.497

6.  Eosinopenia as a marker of diagnosis and prognostic to distinguish bacterial from aseptic meningitis in pediatrics.

Authors:  Agathe Debray; Sylvie Nathanson; Florence Moulin; Jérome Salomon; Benjamin Davido
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-06-22       Impact factor: 3.267

7.  Management of acute meningitis.

Authors:  Michael J Griffiths; Fiona McGill; Tom Solomon
Journal:  Clin Med (Lond)       Date:  2018-03       Impact factor: 2.659

8.  Multivariate approach to differential diagnosis of acute meningitis.

Authors:  B Hoen; J F Viel; C Paquot; A Gérard; P Canton
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-04       Impact factor: 3.267

9.  A diagnostic decision rule for management of children with meningeal signs.

Authors:  Rianne Oostenbrink; Karel G M Moons; Carl G M Moons; Arda G Derksen-Lubsen; Diederick E Grobbee; Henriette A Moll
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

10.  Risk score for identifying adults with CSF pleocytosis and negative CSF Gram stain at low risk for an urgent treatable cause.

Authors:  Rodrigo Hasbun; Merijn Bijlsma; Matthijs C Brouwer; Nabil Khoury; Christiane M Hadi; Arie van der Ende; Susan H Wootton; Lucrecia Salazar; Md Monir Hossain; Mark Beilke; Diederik van de Beek
Journal:  J Infect       Date:  2013-04-22       Impact factor: 6.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.